Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

10:00 ET InventHelp Inventor Develops Vehicle Changing Station for Babies (ORD-2871)

"I wanted to create a better way to change a diaper in the back of the car," said an inventor, from Polk City, Fla., "so I invented the CONVENIENT...


09:59 ET New Dupixent® (dupilumab) Data Showcasing Improvements Across Four Type 2 Inflammatory Diseases to be Presented at 2021 AAAAI Annual Meeting

Improvements were noted across key disease measures in certain patients with asthma, atopic dermatitis, eosinophilic esophagitis and chronic...


09:15 ET Ampio Announces Early Positive Data in Phase 1 Trial of Inhaled Ampion in COVID-19 Respiratory Distress

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent ...


09:03 ET SMART Study Finds 22q11.2 Microdeletion Prevalence Much Higher than Expected

Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cfDNA testing, presented key results from its SMART study at the SMFM 41st Annual...


09:00 ET Can Brain Implants Improve Mobility After Stroke?

Someone has a stroke every 40 seconds in the US, resulting in death every 4 minutes. Stroke is the leading cause of disability from a medical...


08:38 ET Choroideremia Research Foundation Supports New Research to Expand Knowledge of This Rare Inherited Retinal Disease

The Choroideremia Research Foundation (CRF) is pleased to announce funding for its first research study in 2021 to Mariya Moosajee, MBBS, BsC (Hons), ...


08:31 ET Circularity Healthcare Announces Expansion with Global CRO of Series of Successful Pivotal Human Clinical Trials to Study Use of D'OXYVA® for Rapid, Economical and Noninvasive Home Treatment of Diabetic Foot Ulcers (DFU)

Circularity Healthcare announced it had successfully executed a contract with the Professional Educational Research Institute (PERI) in 2020 to...


08:30 ET Emmes Leads Clinical Trials to Improve Pediatric Drug Labeling

Emmes, a global, full-service Clinical Research Organization dedicated to supporting the advancement of public health and biopharmaceutical...


08:16 ET Study Finds MediPines' Breakthrough Non-invasive Gas Exchange Method Highly Precise: Ideal for Covid Response

A recent clinical study published by medical researchers from UC San Diego School of Medicine has established that an expired breath sampling method...


08:00 ET Aikido Pharma Secures Early Interest in Next Generation Radiotherapy

AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company executed a Two Million Dollar Convertible Promissory...


08:00 ET Immunexpress Presents Data Further Demonstrating SeptiCyte® RAPID Performance at the Society of Critical Care Medicine's 50th Annual Critical Care Congress

Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, today announced a research snapshot...


07:45 ET Creative Medical Technology Holdings Identifies and Files Patent on Novel Mechanism of ImmCelz® Therapeutic Activity

(OTC – CELZ) Creative Medical Technology Holdings, Inc. announced today new data demonstrating that administration of ImmCelz® to animals with a...


07:30 ET Moleculin Signs Agreement with Catalyst Clinical Research to Begin Sarcoma Trial

Moleculin Biotech, Inc., (Nasdaq: MBRX) (Moleculin or the Company), a clinical stage pharmaceutical company with a broad portfolio of drug candidates ...


07:30 ET Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move Forward with its JT-09 ProNeura® Development Program

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced that studies of its kappa opioid agonist peptide, JT-09, has demonstrated high potency and ...


07:14 ET Crafoord Laureate discovered the explanation for mysterious fevers

Dan Kastner, USA, has described an entirely new group of rare autoinflammatory diseases. His discoveries have brought new knowledge and led to the...


07:11 ET SIFI Announces the Publication of its Phase I Study on Polihexanide in the British Journal of Ophthalmology

SIFI, a leading ophthalmic company, announced today the publication of clinical results from its Phase I trial of polihexanide in healthy volunteers. ...


07:05 ET REGENXBIO Announces Presentations at the 17th Annual WORLDSymposium™ 2021

REGENXBIO Inc. (Nasdaq: RGNX) today announced that three oral and nine poster presentations will be presented at the 17th Annual WORLDSymposium™,...


07:00 ET Pharvaris to Present Clinical Data of PHA121 for the Treatment of Hereditary Angioedema at the 2021 AAAAI Annual Meeting

Pharvaris, a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies, including ...


07:00 ET Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company committed to developing transformative biologics as vaccines and...


06:50 ET Protalix BioTherapeutics Announces Presentations at the 17th Annual WORLDSymposium™ 2021

Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and...


06:41 ET SIFI anuncia la publicación del ensayo en Fase I sobre polihexanida en el British Journal of Ophthalmology

SIFI, destacada compañía de oftalmología, anunció hoy la publicación de los resultados clínicos de un ensayo en Fase I de polihexanida en voluntarios ...


06:00 ET SIFI annonce la publication de son étude portant sur la phase I sur le polihexanide dans le British Journal of Ophthalmology

SIFI, une entreprise ophtalmique de premier plan, a annoncé aujourd'hui la publication des résultats cliniques de son essai de phase I sur le...


06:00 ET SIFI gibt die Veröffentlichung der Phase 1 seiner Studie über Polihexanid in dem British Journal of Ophthalmology bekannt

SIFI, ein führendes Unternehmen aus dem Bereich Augenheilkunde hat heute die Veröffentlichung der klinischen Ergebnisse der Phase 1 seiner Studie an...


02:17 ET Positive data from Phase II study ATTRACT in patients with COVID-19 published online: Vicore Pharma Holding

Vicore Pharma Holding AB (publ), a pharmaceutical company dedicated to developing innovative medicines for severe lung disorders, today published...


01:00 ET Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company committed to developing transformative biologics as vaccines and...